ABX-CRO advanced pharmaceutical services
ABX-CRO, paving your way into the theranostics landscape
ABX-CRO is a globally operating clinical research organisation with a strong focus on pre-clinical and clinical molecular imaging and molecular radiotherapy.
Based on over 15 years of experience in diagnostic and therapeutic oncology, neurology and other disease areas, ABX-CRO provides you with unique opportunities to test your drug candidates in complex pre-clinical disease models, assessed quantitatively using molecular and functional imaging (PET, SPECT, CT, MRI). We translate pre-clinical results into First in Man studies and support you with design and execution of efficient late stage clinical trials, minimizing your costs and time to marketing authorization. ABX-CRO makes translational medicine a visible reality.
To facilitate your molecular radiotherapy development or daily clinical practice, we are presenting QDOSE, our comprehensive software suite for internal dosimetry. QDOSE is a versatile stand-alone, user-friendly, vendor-neutral software solution, integrating all steps required to do a full dosimetry from image import to a report with maximum flexibility. It includes multiple workflows in one package: planar, hybrid, volumetric and SIRT dosimetry. See the new ICRP endorsed dosimetry calculation tool IDAC 2.0 featuring the ICRP reference phantom integrated in QDOSE.